Practical Strategies for Identifying and Screening for Hypercortisolism - Episode 6
Importance of Primary Care in Identification and Screening for Hypercortisolism
Experts discuss how the clinical presentation of hypercortisolism differs in the primary care vs specialist setting, highlighting earlier signs/symptoms vs overt disease, and review recent data on the prevalence of hypercortisolism, including its higher occurrence in patients with difficult-to-control diabetes, difficult-to-control hypertension, and cardiovascular disease.
Video content above is prompted by the following:
- How would the clinical presentation of hypercortisolism differ in the primary care vs specialist setting?
- Earlier signs/symptoms vs overt disease
- The prevalence of hypercortisolism in certain at-risk patients is higher than previously thought. Can you discuss some of the recent data on hypercortisolism prevalence?
- Prevalence of hypercortisolism in patients with difficult-to-control diabetes was 24%.
- Prevalence of hypercortisolism in patients with difficult-to-control diabetes and difficult-to-control hypertension was 40%.
- Patients with cardiovascular disease had a higher prevalence of hypercortisolism than those without (33.3% vs 20.9%).
